These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 7691944

  • 1. Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF.
    Li B, Sallee C, Dehoff M, Foley S, Molina H, Holers VM.
    J Immunol; 1993 Oct 15; 151(8):4295-305. PubMed ID: 7691944
    [Abstract] [Full Text] [Related]

  • 2. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
    Kim YU, Kinoshita T, Molina H, Hourcade D, Seya T, Wagner LM, Holers VM.
    J Exp Med; 1995 Jan 01; 181(1):151-9. PubMed ID: 7528766
    [Abstract] [Full Text] [Related]

  • 3. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.
    Sohn JH, Kaplan HJ, Suk HJ, Bora PS, Bora NS.
    Invest Ophthalmol Vis Sci; 2000 Oct 01; 41(11):3492-502. PubMed ID: 11006244
    [Abstract] [Full Text] [Related]

  • 4. Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells.
    Fernández-Centeno E, de Ojeda G, Rojo JM, Portolés P.
    J Immunol; 2000 May 01; 164(9):4533-42. PubMed ID: 10779754
    [Abstract] [Full Text] [Related]

  • 5. Rat T cells express neither CD55 nor CD59 and are dependent on Crry for protection from homologous complement.
    Hanna S, Spiller O, Linton SM, Mead RJ, Morgan B.
    Eur J Immunol; 2002 Feb 01; 32(2):502-9. PubMed ID: 11828367
    [Abstract] [Full Text] [Related]

  • 6. Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor.
    Molina H, Miwa T, Zhou L, Hilliard B, Mastellos D, Maldonado MA, Lambris JD, Song WC.
    Blood; 2002 Dec 15; 100(13):4544-9. PubMed ID: 12393518
    [Abstract] [Full Text] [Related]

  • 7. Mouse Crry/p65 is a regulator of the alternative pathway of complement activation.
    Foley S, Li B, Dehoff M, Molina H, Holers VM.
    Eur J Immunol; 1993 Jun 15; 23(6):1381-4. PubMed ID: 8500531
    [Abstract] [Full Text] [Related]

  • 8. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
    Miwa T, Zhou L, Hilliard B, Molina H, Song WC.
    Blood; 2002 May 15; 99(10):3707-16. PubMed ID: 11986227
    [Abstract] [Full Text] [Related]

  • 9. Molecular cloning, expression and characterization of the rat analogue of human membrane cofactor protein (MCP/CD46).
    Mead R, Hinchliffe SJ, Morgan BP.
    Immunology; 1999 Sep 15; 98(1):137-43. PubMed ID: 10469244
    [Abstract] [Full Text] [Related]

  • 10. Retrovirus-mediated over-expression of decay-accelerating factor rescues Crry-deficient erythrocytes from acute alternative pathway complement attack.
    Kim DD, Miwa T, Song WC.
    J Immunol; 2006 Oct 15; 177(8):5558-66. PubMed ID: 17015743
    [Abstract] [Full Text] [Related]

  • 11. Levels of complement regulatory molecules in lung cancer: disappearance of the D17 epitope of CD55 in small-cell carcinoma.
    Sakuma T, Kodama K, Hara T, Eshita Y, Shibata N, Matsumoto M, Seya T, Mori Y.
    Jpn J Cancer Res; 1993 Jul 15; 84(7):753-9. PubMed ID: 7690355
    [Abstract] [Full Text] [Related]

  • 12. Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46).
    Seya T, Hara T, Matsumoto M, Sugita Y, Akedo H.
    J Exp Med; 1990 Dec 01; 172(6):1673-80. PubMed ID: 2258699
    [Abstract] [Full Text] [Related]

  • 13. DAF/Crry double deficiency in mice exacerbates nephrotoxic serum-induced proteinuria despite markedly reduced systemic complement activity.
    Miwa T, Zhou L, Tudoran R, Lambris JD, Madaio MP, Nangaku M, Molina H, Song WC.
    Mol Immunol; 2007 Jan 01; 44(1-3):139-46. PubMed ID: 16887189
    [Abstract] [Full Text] [Related]

  • 14. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
    Iwata K, Seya T, Ariga H, Nagasawa S.
    J Immunol; 1994 Apr 01; 152(7):3436-44. PubMed ID: 7511647
    [Abstract] [Full Text] [Related]

  • 15. Deletion of Crry and DAF on murine platelets stimulates thrombopoiesis and increases factor H-dependent resistance of peripheral platelets to complement attack.
    Barata L, Miwa T, Sato S, Kim D, Mohammed I, Song WC.
    J Immunol; 2013 Mar 15; 190(6):2886-95. PubMed ID: 23390291
    [Abstract] [Full Text] [Related]

  • 16. A monoclonal antibody to the rat Crry/p65 antigen, a complement regulatory membrane protein, stimulates adhesion and proliferation of thymocytes.
    Arsenović-Ranin N, Vucević D, Okada N, Dimitrijević M, Colić M.
    Immunology; 2000 Jul 15; 100(3):334-44. PubMed ID: 10929055
    [Abstract] [Full Text] [Related]

  • 17. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
    Lublin DM, Coyne KE.
    J Exp Med; 1991 Jul 01; 174(1):35-44. PubMed ID: 1711565
    [Abstract] [Full Text] [Related]

  • 18. Mouse complement receptor-related gene y/p65-neutralized tumor vaccine induces antitumor activity in vivo.
    Ohta R, Kondor N, Dohi N, Tomlinson S, Imai M, Holers VM, Okada H, Okada N.
    J Immunol; 2004 Jul 01; 173(1):205-13. PubMed ID: 15210776
    [Abstract] [Full Text] [Related]

  • 19. Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation.
    Seya T, Hara T, Matsumoto M, Akedo H.
    J Immunol; 1990 Jul 01; 145(1):238-45. PubMed ID: 1694203
    [Abstract] [Full Text] [Related]

  • 20. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.
    Kuraya M, Yefenof E, Klein G, Klein E.
    Eur J Immunol; 1992 Jul 01; 22(7):1871-6. PubMed ID: 1378022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.